Crescent Biopharma, Inc. 13F holders
80 funds reported a position in Crescent Biopharma, Inc. in their 13F for the quarter ended 30 June 2026, together 29.1 million shares worth $524.1 million. Against the quarter before, 31 opened a position, 17 added, 14 trimmed and 12 sold out; together they bought a net 4.0 million shares. The largest holders: FMR LLC, BVF Inc. and Fairmount Funds Management LLC.
Funds holding80+20 on Q1 2026
Shares they held29.1Mworth $524.1 million
Net bought on the quarter4.0M sharesabout $71.8 million at the funds' values
Funds buying to selling48 to 26opened or added, to cut or sold
Opened 31Added 17Held 18Trimmed 14Sold out 12
What each fund did in CBIO against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in CBIO in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
3,241 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 11 reported a position in Crescent Biopharma, Inc.: 6 opened one, 3 added, 0 trimmed and 1 sold out, a net 49,416 shares sold.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Sterling Capital Management LLC | +884 | 960 | added | 13F |
| Farther Finance Advisors, LLC | +215 | 215 | new | 13F |
| Gamma Investing LLC | +148 | 148 | new | 13F |
| Caitong International Asset Management Co., Ltd | +82 | 103 | added | 13F |
| Signaturefd, LLC | +67 | 67 | new | 13F |
| IFP Advisors, Inc | +5 | 5 | new | 13F |
| Essential Partners LLC | +3 | 3 | new | 13F |
| SBI Securities Co., Ltd. | +3 | 71 | added | 13F |
| SJS Investment Consulting Inc. | +1 | 1 | new | 13F |
| Y-Intercept (Hong Kong) Ltd | -50,824 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 5 reported a position in Crescent Biopharma, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 4.1 million shares worth $74.4 million, 0.0% of its reported book. Sold out: Renaissance Technologies, Alyeska. In the quarter, 3 funds added or opened a position and 2 trimmed or sold out; together they bought a net 143,445 shares, about $2.6 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 4,133,514 | $74.4 million | 0.0% | no change | held | 30 June 2026 | 13F |
| Millennium Management | 403,859 | $7.3 million | 0.0% | +80,306 | added | 30 June 2026 | 13F |
| Geode Capital Management | 384,576 | $6.9 million | 0.0% | +280,355 | added | 30 June 2026 | 13F |
| Point72 Asset Management | 300,000 | $5.4 million | 0.0% | no change | held | 30 June 2026 | 13F |
| Two Sigma Investments | 186,874 | $3.4 million | 0.0% | +71,046 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 0 | $0 | 0.0% | -24,262 | exited | 30 June 2026 | 13F |
| Alyeska | 0 | $0 | 0.0% | -264,000 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| FMR LLC | 4,133,514 | 14.20% | $74.4 million | 0.00% | no change | 13F |
| BVF Inc. | 2,748,763 | 9.44% | $49.5 million | 1.26% | no change | 13F |
| Fairmount Funds Management LLC | 2,747,866 | 9.44% | $49.5 million | 3.27% | no change | 13F |
| Venrock Adviser, LLC | 2,133,576 | 7.33% | $38.4 million | 1.16% | no change | 13F |
| Logos Global Management LP | 1,900,000 | 6.53% | $34.2 million | 1.47% | +1,417,500 | 13F |
| Fcpm III Services B.V. | 1,677,852 | 5.76% | $30.2 million | 4.03% | no change | 13F |
| Balyasny Asset Management L.P. | 1,662,917 | 5.71% | $29.9 million | 0.06% | +152,884 | 13F |
| Vestal Point Capital, LP | 1,630,000 | 5.60% | $29.3 million | 0.69% | +130,000 | 13F |
| Opaleye Management Inc. | 1,319,351 | 4.53% | $23.7 million | 2.15% | +6,736 | 13F |
| BlackRock, Inc. | 1,271,762 | 4.37% | $22.9 million | 0.00% | +1,156,037 | 13F |
| Tang Capital Management LLC | 1,160,000 | 3.98% | $20.9 million | 0.95% | no change | 13F |
| Vanguard Capital Management LLC | 767,755 | 2.64% | $13.8 million | 0.00% | -33,640 | 13F |
| Millennium Management LLC | 403,859 | 1.39% | $7.3 million | 0.01% | +80,306 | 13F |
| Geode Capital Management, LLC | 384,576 | 1.32% | $6.9 million | 0.00% | +280,355 | 13F |
| Jennison Associates LLC | 378,507 | 1.30% | $6.8 million | 0.00% | +225,533 | 13F |
| NEXTBio Capital Management LP | 372,856 | 1.28% | $6.7 million | 3.09% | no change | 13F |
| RTW Investments, LP | 372,856 | 1.28% | $6.7 million | 0.06% | no change | 13F |
| Remedium Capital Partners, LLC | 361,250 | 1.24% | $6.5 million | 1.44% | new | 13F |
| State Street Corp. | 315,587 | 1.08% | $5.7 million | 0.00% | +276,520 | 13F |
| Ameriprise Financial Inc. | 302,568 | 1.04% | $5.4 million | 0.00% | new | 13F |
| Point72 Asset Management, L.P. | 300,000 | 1.03% | $5.4 million | 0.01% | no change | 13F |
| Price T Rowe Associates Inc. | 275,581 | 0.95% | $5.0 million | 0.00% | -27,970 | 13F |
| Marshall Wace, LLP | 214,300 | 0.74% | $3.9 million | 0.00% | +13,520 | 13F |
| Perceptive Advisors LLC | 206,942 | 0.71% | $3.7 million | 0.06% | no change | 13F |
| Vanguard Portfolio Management LLC | 188,803 | 0.65% | $3.4 million | 0.00% | new | 13F |
| Two Sigma Investments, LP | 186,874 | 0.64% | $3.4 million | 0.00% | +71,046 | 13F |
| Stempoint Capital LP | 182,382 | 0.63% | $3.3 million | 0.57% | new | 13F |
| UBS Group AG | 175,182 | 0.60% | $3.2 million | 0.00% | +92,476 | 13F |
| Northern Trust Corp. | 138,778 | 0.48% | $2.5 million | 0.00% | +121,549 | 13F |
| Exome Asset Management LLC | 127,769 | 0.44% | $2.3 million | 1.42% | -25,422 | 13F |
| Sectoral Asset Management Inc. | 121,300 | 0.42% | $2.2 million | 1.52% | new | 13F |
| Woodline Partners LP | 94,488 | 0.32% | $1.7 million | 0.01% | +20,488 | 13F |
| Vanguard Fiduciary Trust Co. | 75,225 | 0.26% | $1.4 million | 0.00% | +25,802 | 13F |
| Burkehill Global Management, LP | 74,000 | 0.25% | $1.3 million | 0.05% | no change | 13F |
| Blackstone Inc. | 62,647 | 0.22% | $1.1 million | 0.00% | new | 13F |
| Silverarc Capital Management, LLC | 59,104 | 0.20% | $1.1 million | 0.12% | -71,396 | 13F |
| Y-Intercept (Hong Kong) Ltd | 50,824 | 0.17% | $914,832 | 0.02% | new | 13F |
| Charles Schwab Investment Management Inc. | 50,258 | 0.17% | $904,644 | 0.00% | new | 13F |
| Nuveen, LLC | 47,629 | 0.16% | $857,322 | 0.00% | new | 13F |
| Bank of New York Mellon Corp | 45,778 | 0.16% | $824,004 | 0.00% | new | 13F |
| Stonepine Capital Management, LLC | 40,000 | 0.14% | $720,000 | 0.55% | -45,000 | 13F |
| Bank of America Corp. | 25,821 | 0.09% | $464,778 | 0.00% | -3,456 | 13F |
| Rhumbline Advisers | 25,487 | 0.09% | $458,766 | 0.00% | new | 13F |
| Moore Capital Management, LP | 25,000 | 0.09% | $450,000 | 0.01% | no change | 13F |
| Squarepoint Ops LLC | 24,166 | 0.08% | $434,988 | 0.00% | new | 13F |
| American Century Companies Inc. | 22,805 | 0.08% | $410,490 | 0.00% | new | 13F |
| Wells Fargo & Company | 19,700 | 0.07% | $354,600 | 0.00% | new | 13F |
| ADAR1 Capital Management, LLC | 18,275 | 0.06% | $328,950 | 0.02% | -31,998 | 13F |
| Virtus Investment Advisers, LLC | 18,258 | 0.06% | $328,644 | 0.08% | new | 13F |
| Manufacturers Life Insurance Company, the | 17,755 | 0.06% | $319,590 | 0.00% | -7,148 | 13F |
The 50 largest of the 80 funds that reported a position in CBIO in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 27 October 2026 | 13G | BlackRock, Inc. and 1 other | 2.1 million | 5.6% | 30 September 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 14 August 2026 | 13G/A | Balyasny Asset Management L.P. and 9 others | 1.7 million | 6.0% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 20 July 2026 | 13D/A | Fairmount Funds Management LLC and 3 others | 6.6 million | 16.5% | 16 July 2026 | Item 4 of the Statement is hereby amended and supplemented as follows: Fund II purchased the Ordinary Shares and Pre-funded Warrants referenced in Item 3 for investment purposes. Lock-Up Agreement In connection with the Company's underwritt | EDGAR |
| 15 May 2026 | 13G/A | Tang Capital Management, LLC and 11 others | 1.2 million | 4.2% | 31 March 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 15 May 2026 | 13G | Balyasny Asset Management L.P. and 9 others | 1.5 million | 5.5% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 17 February 2026 | 13G/A | Venrock Healthcare Capital Partners III, L.P. and 13 others | 2.7 million | 9.5% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 17 February 2026 | 13G | Vestal Point Capital, LP and 3 others | 1.5 million | 5.4% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 5 February 2026 | 13G/A | FMR LLC and 3 others | 4.1 million | 15.0% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 11 December 2025 | 13G | ForGrowth III PA B.V. and 5 others | 1.7 million | 6.1% | 8 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 8 December 2025 | 13D/A | Fairmount Funds Management LLC and 3 others | 5.6 million | 18.5% | 4 December 2025 | Item 4 of the Statement is hereby amended and supplemented as follows: Subscription Agreement On December 4, 2025, the Company entered into a securities purchase agreement (the "Subscription Agreement") for a private investment in public eq | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 24 September 2026 | 2,299 | $14.19 | SEC |
| 2 September 2026 | 42 | $17.93 | SEC |
| 1 September 2026 | 42 | $16.60 | SEC |
| 31 August 2026 | 1,452 | $17.75 | SEC |
| 28 August 2026 | 78 | $17.76 | SEC |
| 26 August 2026 | 167 | $17.00 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.